AKT1 and colorectal cancer: These in vitro and in vivo results revealed that miR-454-3p inhibited oxaliplatin induced-apoptosis and promoted oxaliplatin resistance in colorectal cancer by repressing PTEN expression, thereby enhancing PI3K/AKT signaling pathway (Figure 6D).